87
Views
11
CrossRef citations to date
0
Altmetric
GHB

Hazardous Use of Gamma Hydroxybutyrate: Driving Under the Influence

&
Pages 1507-1520 | Published online: 03 Jul 2009

References

  • Akram G., Forsyth A. J. M. Speed Freaks? A literature review detailing the nature and prevalence of dance drugs and driving. International Journal of Drug Policy 2000; 11: 265–277
  • Albery I. P., Strang J., Gossop M., Griffiths P. Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug and Alcohol Dependence 2000; 58: 197–204
  • Anderson I. B., Kim S. Y., Dyer J. E., Burkhardt C. B., Iknoian J. C., Walsh M. J., et al. Trends in gamma hydroxybutyrate (GHB) and related drug intoxication: 1999–2003. Annals of Emergency Medicine 2006; 47(2)177–183, Epub Dec 28, 2005
  • Barker J. C., Harris S. L., Dyer J. E. Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study. Journal of Psychoactive Drugs 2007; 39: 115–129
  • Bloor M., Frankland J., Thomas M., Robson K. Focus groups in social research. Sage, London 2001
  • Behrensdorff I., Steentoft A. Medicinal and illegal drugs among Danish car drivers. Accident Analysis and Prevention 2003; 35: 851–860
  • Bosman I. J., Lusthof K. Forensic cases involving the use of GHB in the Netherlands. Forensic Science International 2003; 133: 17–21
  • Bradbeer T., Ormsby J., Fleming P. Questionnaire survey of automobile driving among users of a substance misuse service. Psychiatric Bulletin 2001; 25: 252–254
  • Brewer R. D., Morris P. D. The risk of dying in alcohol-related automobile crashes among habitual drunk drivers. New England Journal of Medicine 1994; 331: 513–517
  • Colfax G. N., Mansergh G., Guzman R., Vittinghoff E., Marks G., Rader M., et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. Journal of Acquired Immune Deficiency Syndrome 2001; 28: 373–379
  • Couper F. J., Logan B. K. Addicted to driving under the influence—a GHB/GBL case report. Journal of Analytical Toxicology 2004; 28
  • Degenhardt L., Darke S., Dillon P. GHB use among Australians: Characteristics, use patterns, and associated harm. Drug and Alcohol Dependence 2002; 67: 89–94
  • Degenhardt L., Darke S., Dillon P. The prevalence and correlates of GHB overdose among Australian users. Addiction 2003; 98(2)199–204
  • Degenhardt L., Dillon P., Duff C., Ross J. Driving, drug use behavior and risk perceptions of nightclub attendees in Victoria, Australia. International Journal of Drug Policy 2006; 17: 41–46
  • Drummer O. H., Gerostamoulos J., Batziris H., Chu M., Capelhorn J., Robertson M. D., et al. The involvement of drugs in drivers of motor vehicles killed I Australian road traffic crashes. Accident, Analysis and Prevention 2004; 36: 239–248
  • Duff C. ‘Charging’ and ‘Blowing Out’: Patterns and cultures of GHB use in Melbourne, Australia. Contemporary Drug Problems 2005; 32: 605–653
  • Duff C., Rowland B. ‘Rushing behind the wheel’: Investigating the prevalence of ‘drug driving’ among club and drug rave patrons in Melbourne, Australia. Drugs: Education, Prevention and Policy 2006; 13(4)299–312
  • Dyer J. E., Haller C. A. Abstract: GHB related fatalities. Journal of Toxicology: Clinical Toxicology 2001; 39(5)518
  • Dyer J. E., Anderson I. B., Kim S. Y., Barker J. C., Blanc P. D. Designing a gammahydroxybutyrate (GHB) structured telephone-administered survey instrument. Journal of Medical Toxicology 2007; 3: 7–14
  • Elliot M. R., Shope J. T., Raghunathan T. E., Waller P. F. Gender differences among young drivers in the association between high-risk driving and substance use/environmental influences. Journal of Studies on Alcohol 2006; 67(2)252–260
  • Farrow J. A., Brissing P. Risk for DWI: a new look at gender differences in drinking and driving influences, experiences, and attitudes among new adolescent drivers. Health Education Quarterly 1990; 17: 213–221
  • Higson R., Winter M. Epidemiology and consequences of drinking and driving. Alcohol Research and Health 2003; 27(1)63–78
  • Jones C., Donnely N., Swift W., Weatherburn D. Preventing cannabis users from driving under the influence of cannabis. Accident Analysis and Prevention 2006; 38: 854–861
  • Karlsson G., Halldin J., Leifman A., Bergman H., Romelsjo A. Hospitalization and mortality succeeding drunk driving and risky driving. Alcohol and Alcoholism 2003; 38(3)281–286
  • Kim S. Y., Dyer J. E., Anderson I. B., Barker J. C., Blanc P. D. High risk behaviors and hospitalizations among gammahydroxybutyrate (GHB) users. American Journal of Drug and Alcohol Abuse 2007; 33: 115–129
  • Krueger R. A. Focus groups: A practical guide for applied research. Sage, Thousand Oaks, CA 1988
  • Laapotti S., Keskinen E., Rajalin S. Comparison of young male and female drivers' attitude and self-reported traffic behavior in Finland in 1978 and 2001. Journal of Safety Research 2003; 34(5)579–587
  • Lenton S., Davidson P. Raves, drugs, dealing and driving: Qualitative data from a West Australian sample. Drugs and Alcohol Review 1999; 18: 153–161
  • Longo M. C., Hunter C. E., Lokan R. J., White J. M., White M. A. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability. Part I: the prevalence of drug use in drivers, and characteristics of the drug-positive group. Accident Analysis and Prevention 2000; 32: 613–622
  • McDowell D. Gay men, lesbians and substances of abuse and the “club and circuit party scene”: What clinicians should know. Journal of Gay and Lesbian Psychotherapy 2000; 3(3–4)37–57
  • Mansergh G., Colfax G. N., Marks G., Rader M., Guzman R., Buchbinder S. The circuit party men's health survey: findings and implications for gay and bisexual men. American Journal of Public Health 2001; 91(6)953–958
  • Mattison A. M., Ross M. W., Wolfson T., Franklin D., San Diego H., IV, Neurobehavioral Research Center Group. Circuit party attendance, club drug use and unsafe sex in gay men. Journal of Substance Abuse 2001; 13: 119–126
  • Maxwell J. C. Party drugs: Properties, prevalence, patterns, and problems. Substance Use and Misuse 2005; 40: 1203–1240
  • Miotto K., Darakjian J., Basch J., Murray S., Zogg J., Rawson R. Gamma-hydroxybutric Acid: Patterns of use, effects and withdrawal. American Journal on Addictions 2001; 10: 232–241
  • Morgan D. A. Focus groups as qualitative research. Sage, Thousand Oaks, CA 1996
  • Movig K. L. L., Mathijssen M. P. M., Nagel P. H. A., Egmond T. V., de Gier J. J., Leufkens H. G. M., et al. Psychoactive substance use and the risk of motor vehicle accidents. Accident Analysis and Prevention 2004; 36: 631–636
  • NHTSA—National Highway Traffic Safety Administration. Traffic safety facts 2005 (Early Edition). U.S. Department of Transportation, Washington, DC 2006, Pub. No. DOT HS-810-631
  • NIDA—National Institute on Drug Abuse. Drugs of Abuse: Club Drugs, Retrieved December 12, 2006, from http://www.drugabuse.gov
  • Neale J. Driving on recreational drugs: a qualitative investigation of experiences from behind the wheel. Drugs: Education, Prevention and Policy 2001; 8(4)315–325
  • Palamar J. J., Halkitis P. N. A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. International Journal of Drug Policy 2006; 17: 23–28
  • Snead O. C., III, Gibson K. M. Gamma-hydroxybutyric acid. New England Journal of Medicine 2005; 352(26)2721–273
  • U.S. Census Bureau. American Community Survey Data Profile Highlights:. 2005, Retrieved January 4, 2007, from http://factfinder.census.gov/home/saff/main.html?_lang=en San Francisco County, California
  • U.S. Drug Enforcement Administration. GHB. 2006, Retrieved December 20, 2006, from http://www.usdoj.gov/dea/concern/ghb_factsheet.html Facts.
  • Vaez M., Laflamme L. Impaired driving and motor vehicle crash among Swedish youth: An investigation into drivers' sociodemographic characteristics. Accident Analysis and Prevention 2005; 37: 605–611
  • Zvosec D. L., Smith S. W., McCutcheon J. R., Spillane J., Hall B. J., Peacock E. A. Adverse events, including death, associated with the use of 1,4-butanediol. New England Journal of Medicine 2001; 344(2)87–94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.